Over the past few weeks, AstraZeneca, Pfizer, and Moderna have given us a little bit of hope, reporting that their coronavirus vaccine candidates showed to be effective (although to different degrees) in phase 3 clinical trials. For the first time in a long time, there’s a light at the end of the pandemic’s tunnel. This time next year, the economy could be close to being back to normal.
Before the economy and struggling stocks completely recover, investors may want to consider buying shares of Merck (NYSE: MRK), JPMorgan Chase (NYSE: JPM), and American Airlines (NASDAQ: AAL), which could be performing a whole lot better a year from now. Here’s a look at how these companies have been doing this year and why it might be prudent to scoop up their shares today.
Image source: Getty Images.
Healthcare company Merck has had a